Friday, February 11, 2011

Natco Pharma challenges Gilead patent on Tamiflu

MoneyControl writes: Natco Pharma has challenged a patent on Tamiflu (Oseltamivir Phosphate)—a drug used in the treatment of bird and swine-flu infections, reports the PTI.

See previous IPBiz posts, including

More on Tamiflu and Gilead's US 5,763,483

keywords: Hatch-Waxman, ANDA


Post a Comment

<< Home